ROSEN, NATIONAL TRIAL LAWYERS, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses over $100K to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results On May 4 Medical Device Investing
 CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal... Biotech Investing
Abbott Receives CE Mark Approval for Next-Generation TriClip Device, Offering New Innovations for Tricuspid Heart Valve Repair Medical Device Investing
Bristol Myers Squibb Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Merck's KEYTRUDA® Demonstrated Superior Disease-Free Survival Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma Following Surgery Pharmaceutical Investing
Aurinia Presents Data Demonstrating LUPKYNIS Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings Biotech Investing
FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival Biotech Investing
